[Coronary artery bypass graft in adolescent suffering from homozygous familial hypercholesterolemia resistant to probucol therapy].
Homozygous familial hypercholesterolemia is a rare hypercholesterolemia representing 1 to 2% of hypercholesterolemia. It is a metabolic disorder coming from genetic trouble with a bad prognostic. Its probucol's therapy in an adolescent is subject of controversy. The authors report a new case diagnosed in an adolescent of 15-year-old followed after CABG in the Thoracic and cardiovascular surgery Department of National Heart Institute Imbaba-Cairo (Egypt).